Edgewise Therapeutics Inc. Common Stock vs Helmerich & Payne Inc. Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.14 (market cap $4.02B), while Helmerich & Payne Inc. Common Stock trades at $38.25 (market cap $3.86B). The key difference: Edgewise Therapeutics Inc. Common Stock and Helmerich & Payne Inc. Common Stock are close in size by market cap, and Helmerich & Payne Inc. Common Stock pays a 2.59% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Helmerich & Payne Inc. Common Stock for 0 Days on average.
| EWTX | HP | |
|---|---|---|
Market Cap | $4.02B | $3.86B |
Volume | 1,446,128 | 870,371 |
Sector | Health | Energy |
52-Week High | $48.35 | $47.64 |
52-Week Low | $14.89 | $23.11 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.56B | $5.49B |
Dividend Yield | — | 2.59% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Helmerich & Payne, Inc. is a US drilling contractor that designs, builds, and operates high-performance land and offshore drilling rigs for oil and gas producers worldwide.
Read more on HP →